 Isolation physicochemical characterization preclinical efficacy evaluation soluble scleroglucan Herein isolation physicochemical characterization preclinical evaluation water-soluble biologic response modifier Sclerotium glucanicum Alkaline extraction insoluble glucanicum exopolymers soluble scleroglucan triple-helical glucopyranose backbone single glucopyranosyl branches third subunit Scleroglucan weight average molecular mass Da weight average root mean square distance center gravity molecule elements nm polydispersity weight-average molecular mass/number average molecular mass intrinsic viscosity dl/g Scleroglucan mg/kg vivo murine macrophage phagocytic activity vitro macrophage tumor cytotoxicity syngeneic tumor targets Scleroglucan murine bone marrow proliferation biphasic manner Scleroglucan therapy survival mice syngeneic lymphoma melanoma adenocarcinoma AKR/J mice syngeneic lymphoma cells long-term survival days mice syngeneic melanoma cells increased long-term survival mice syngeneic adenocarcinoma cells median survival time addition scleroglucan prophylaxis resistance mice Staphylococcus aureus Candida albicans mouse hepatitis virus Scleroglucan toxicity hepatomegaly water-soluble scleroglucan biologic response modifier glucanicum scleroglucan immunity experimental neoplastic disease resistance microbial challenge scleroglucan shows immunopotentiating drug